Tag: DOORwaY90
Interim findings for SIR-Spheres resin microspheres in unresectable HCC strengthen radioembolization’s...
This advertorial is sponsored by Sirtex Medical.
Although early, findings from the DOORwaY90 trial have prompted discussion on both sides of the Atlantic regarding the...
DOORwaY90 study signals strong efficacy and safety for SIR-Spheres in unresectable...
This advertorial is sponsored by Sirtex Medical.
Interim data from the DOORwaY90 study, a prospective, multicentre, open-label, single-arm trial evaluating SIR-Spheres yttrium-90 (Y-90) resin microspheres...
DOORwaY90 clinical trial interim analysis demonstrates efficacy of Y-90 resin microspheres...
An interim analysis of the DOORwaY90 clinical trial has shown that yttrium-90 (Y-90) resin microspheres—SIR-Spheres (Sirtex)—using partition dosimetry, achieved high objective response rates and...
